As of June 21, 2025, T2 Biosystems Inc (TTOO) reports a Forward P/E of N/A.
Forward P/E gauges the price investors pay for each dollar of anticipated earnings, offering insight into a stock's future valuation.
Comparing T2 Biosystems Inc's Forward P/E to Peers
To better understand T2 Biosystems Inc's position, it's useful to compare its Forward P/E against industry peers. Below are selected comparisons:
| Company | Forward P/E |
|---|---|
| T2 Biosystems Inc (TTOO) | - |
| ADMA Biologics Inc (ADMA) | 28.12 |
| Vertex Pharmaceuticals Inc (VRTX) | 24.12 |
| Abbvie Inc (ABBV) | 14.70 |
| Regeneron Pharmaceuticals Inc (REGN) | 14.02 |
| Amgen Inc (AMGN) | 13.75 |
Compared to its competitors, T2 Biosystems Inc's Forward P/E is difficult to compare due to insufficient data.